Inhibition by aspirin of N-[4-(5-nitro-2furyl)-2thiazolyl]formamide induced bladder carcinogenesis and enhancement of forestomach carcinogenesis

Gen'i Murasaki, Terry V. Zenser, Bernard B. Davis, Samuel M. Cohen

Research output: Contribution to journalArticle

68 Scopus citations

Abstract

N-[4-(5-Nitro-2-furyl)-2-thiazolyl]formamide (FANFT) is a potent urinary bladder carcinogen in the rat, and it can be metabolically activated in vitro by a variety of enzyme systems including aerobic cooxidation by prostaglandin H synthase. The latter enzyme is present in the rat bladder mucosa and can be inhibited by the oral administration of aspirin (ASA). To determine if ASA could inhibit the bladder carrinogenidty of FANFT, FANFT (0.2%) was co-administered in the diet with ASA (0.5%) for 12 weeks followed by 1 week of ASA only and then 56 weeks on control diet. 0.2% FANFT followed by control diet induced bladder carcinomas in 18 of 21 (87%) rats, but when ASA was co-administered, only 10 of 27 (37%) rats dweloped bladder cardnoma (p <0.001). However, forestomach tumors, not seen in rats fed only FANFT, developed in 7 rats fed FANFT plus ASA. No tumors occurred in control rats or those fed only ASA. Possible mechanisms, including the role of prostaglandin H synthase in FANFT metabolism, are discussed.

Original languageEnglish (US)
Pages (from-to)53-55
Number of pages3
JournalCarcinogenesis
Volume5
Issue number1
DOIs
StatePublished - Jan 1 1984

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Inhibition by aspirin of N-[4-(5-nitro-2furyl)-2thiazolyl]formamide induced bladder carcinogenesis and enhancement of forestomach carcinogenesis'. Together they form a unique fingerprint.

  • Cite this